Updated January 26, 2018 09:50:00 The US Food and Drug Administration (FDA) announced that the drug, pms, will be phased out by 2021.
Pms was used in a series of tests used to detect pregnancy in the 1980s and 1990s.
Since then, researchers have discovered a number of serious health problems associated with the use of pms in the workplace.
PMS was discovered to cause severe respiratory problems, infertility, birth defects and birth defects in laboratory animals and pregnant women.
Pending regulatory approval, the FDA is expected to announce a change to the labeling for pms.
The agency said in a statement that it plans to phase out the drug in 2020.
P.M. is not FDA-approved for use in pregnant women because the agency does not have data on how it affects the fetus, a human being.
Pm has a lower chance of causing miscarriage, but there is no evidence that the medication causes birth defects or birth defects of the unborn child.
The FDA also announced that it will not recommend or require the use or sale of the drug by hospitals or health care facilities that use it in their facilities.
The decision to phase down the drug comes after a series, which involved thousands of studies, were conducted on the safety and efficacy of p.m.
In 2016, the drug was approved by the FDA for use as a treatment for pregnancy-related conditions.
Pregnancy yoga in the US and other countries The drug was not approved for use by the US in 2016.
However, the US Food & Drug Administration did approve the use in other countries.
The US FDA also said that it would be taking steps to ensure that the drugs use is consistent with the International Standard for the Care and Use of Pregnancy Drugs.
Pmelastrol is approved for the treatment of pregnancy-associated conditions including uterine or endometrial cancer, preeclampsia and pregnancy-induced hypertension.
It is not approved by any country for the use during pregnancy.
Pmalastrol has been shown to have a positive impact on fetal development in laboratory rats and in mice.
Pembos, which are an opioid antagonist, are also approved for treatment of preeclampia, but they have not been tested for use during a pregnancy.
Other drugs to treat preeclamations include oxycodone and methadone.